Cagrilintide

Description

Provided as a lyophilized powder that must be reconstituted using bacteriostatic water prior to research use.
📌 What Is Cagrilintide?
Cagrilintide is a long-acting, investigational analog of the hormone amylin. Amylin works in conjunction with insulin to help control appetite and food intake. Cagrilintide is currently being evaluated for weight reduction and metabolic health, often alongside GLP-1 receptor agonists such as semaglutide.

🔥 Weight Management Lowers appetite and calorie consumption, contributing to fat loss
⚡ Metabolic Function Aids in blood glucose regulation and promotes improved insulin responsiveness
❤️ Cardiometabolic Support May assist with body-weight reduction and improvement of cardiovascular risk indicators
🧠 Appetite Regulation Influences central appetite pathways to increase satiety and limit overeating

⚙️ Mechanism of Action
-Replicates the action of amylin, a natural satiety hormone released with insulin
-Stimulates amylin receptors in the brain, resulting in reduced hunger and slower gastric emptying
-Frequently studied in combination with semaglutide (a GLP-1 agonist) for enhanced weight-loss outcomes

📈 Key Benefits
✅ Effective appetite control
✅ Notable weight reduction observed in clinical trials
✅ Works synergistically with GLP-1–based therapies for obesity management
✅ May help improve insulin sensitivity and overall metabolic balance

⚠️ Important Note
Cagrilintide is not FDA-approved and remains under clinical investigation. Current research is primarily focused on obesity and metabolic disease treatment.